Deferred Income Tax Liabilities, Net of Neuphoria Therapeutics Inc. from 30 Jun 2023 to 31 Dec 2025

Taxonomy & unit: us-gaap: USD
Description: Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.
Summary: Neuphoria Therapeutics Inc. quarterly Deferred Income Tax Liabilities, Net in USD history and change rate from 30 Jun 2023 to 31 Dec 2025.
Neuphoria Therapeutics Inc. Deferred Income Tax Liabilities, Net for the quarter ending 31 Dec 2025 was $425,527, a 50% decline year-over-year.
Source SEC data: View on sec.gov

Deferred Income Tax Liabilities, Net, Quarterly (USD)

Deferred Income Tax Liabilities, Net, YoY Quarterly Change (%)

Neuphoria Therapeutics Inc. Quarterly Deferred Income Tax Liabilities, Net (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed	Fiscal Year	Fiscal Period
Q4 2025	$425,527	-$417,394	-50%	31 Dec 2025	10-Q	17 Feb 2026	2025	Q2
Q3 2025	$460,320	-$371,004	-45%	30 Sep 2025	10-Q	14 Nov 2025	2025	Q1
Q2 2025	$495,113	-$468,427	-49%	30 Jun 2025	10-Q	17 Feb 2026	2025	Q2
Q1 2025	$761,737			31 Mar 2025	10-Q	20 May 2025	2025	Q3
Q4 2024	$842,921			31 Dec 2024	10-Q	14 Feb 2025	2025	Q2
Q3 2024	$831,324			30 Sep 2024	10-Q	14 Nov 2024	2025	Q1
Q2 2024	$963,540	-$139,173	-13%	30 Jun 2024	10-K	29 Sep 2025	2025	FY
Q2 2023	$1,102,713			30 Jun 2023	10-K	30 Sep 2024	2024	FY

* An asterisk sign (*) next to the value indicates that the value is likely invalid.